Filing metadata

Accession number
0001104659-19-047723
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Aug 28, 2019
Reporting period
Aug 27, 2019
Description
Insider transaction

Explore SEC Filings Hub